Furthermore, because of its potential use as a gene therapy vector, researchers have created an altered AAV called self-complementary adeno-associated virus (scAAV).
Ademais, debido ao seu potencial uso como vectores de terapia xénica, os investigadores crearon un virus adenoasociado alterado chamado virus adenoasociado autocomplementario (scAAV).